Chemotherapy for breast cancer in pregnancy: evidence and guidance for oncologists
Authors:
- 16 December 2010
- journal article
- Published by SAGE Publications in Therapeutic Advances in Medical Oncology
- Vol. 3 (2) , 73-83
Abstract
It has been estimated that up to 3.8% of breast cancers may be diagnosed in women who are pregnant, with an estimated 1 in 3000–3500 deliveries occurring in women with breast cancer. Owing to the lack of large randomized trials available to guide our clinical practice, our decisions regarding adjuvant systemic management are based on retrospective analyses, case reports and a small number of prospective studies. A tailored approach to treatment is required with careful consideration given at all stages to the needs of the mother and risks to the foetus. Management is critically influenced by the stage of pregnancy, especially the first trimester. Anthracycline-based chemotherapy may be administered during the second and third trimesters, with apparently few short-term implications. Limited data shows the taxanes may also be given with few adverse events at these stages. Weekly fractionation regimens may allow closer monitoring of pregnancy with prompt termination of agents, if necessary. Data concerning the long-term risks of systemic anticancer treatment are limited. All stages of patient management should be discussed within a multidisciplinary team and a clear consensus of treatment options communicated to the mother. Delaying chemotherapy until after delivery may be reasonable in some cases, but where the delay is likely to be prolonged, a decision must be made on the basis of risks versus benefits.Keywords
This publication has 96 references indexed in Scilit:
- Taxanes for breast cancer during pregnancy: a systematic reviewAnnals of Oncology, 2009
- Breast cancer and pregnancy: how safe is trastuzumab?Nature Reviews Clinical Oncology, 2009
- Pregnancy associated breast cancerEuropean Journal of Surgical Oncology, 2009
- Weekly epirubicin in the treatment of gestational breast cancer (GBC)Breast Cancer Research and Treatment, 2008
- Favorable pregnancy outcome following Trastuzumab (Herceptin®) use during pregnancy—Case report and updated literature reviewReproductive Toxicology, 2007
- Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching HospitalsJournal of Clinical Oncology, 2005
- Treating Breast Cancer During PregnancyDrug Safety, 1998
- Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran)Postgraduate Medical Journal, 1996
- Congenital MalformationsNew England Journal of Medicine, 1983
- CYTOTOXIC DRUGS IN PREGNANCYBJOG: An International Journal of Obstetrics & Gynaecology, 1968